The usefulness of olive oil enema in children with severe chronic constipation

Akiko Yokoi1, Naoko Kamata1

  • 1Department of Pediatric Surgery, Kobe Children's Hospital. 1-6-7, Minatojima Minamimach, Chuoku, Kobe, Japan 650-0047.

Insights

Olive oil enemas are effective for over 75% of children with severe chronic constipation, offering a useful treatment option. This study highlights their utility in managing fecal impaction and aiding disimpaction in pediatric patients.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology

Background:

  • Severe chronic constipation is a significant challenge in pediatric care.
  • Limited data exists on the efficacy of olive oil enemas for this condition.

Purpose of the Study:

  • To evaluate the effectiveness of olive oil enemas in children with severe chronic constipation.
  • To review clinical experience with olive oil enemas in a pediatric surgery setting.

Main Methods:

  • Retrospective chart review of 118 pediatric patients treated with olive oil enemas (January 2010 - November 2019).
  • Olive oil enemas (1-2 ml/kg) were administered alone or followed by glycerin enemas.
  • Efficacy was rated using a standardized scale: very effective (VE), effective (E), limited (L), ineffective (I), and unknown (U).

Main Results:

  • Olive oil enemas were successfully used at home by 97.5% of patients.
  • The treatment was effective for fecal impaction in 77.6% and as a lubricant in 76.9% of patients.
  • Efficacy was consistent across various underlying pediatric gastrointestinal disorders.

Conclusions:

  • Olive oil enemas demonstrate significant utility in managing severe chronic constipation in children.
  • Further research is recommended to establish olive oil enemas as an adjunctive therapy for severe constipation.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...